intravitreal, VEGF Therapy, macula


CLASSIFIEDS

Find the job that’s right for you. PhysiciansJobsPlus allows you to post your resume, receive relevant ophthalmology open position alerts via email and apply for positions online.

Welcome to AMD Update!

It is estimated that 15 million people in the United States have age-related macular degeneration (AMD), with more than 1.75 million having advanced disease (defined as neovascular AMD or geographic atrophy); the number with advanced disease is expected to climb to almost 3 million by the year 2020. AMD is the leading cause of blindness in adults over 55 years of age.

AMD Update is a monthly e-newsletter dedicated to bringing to the ophthalmologist the latest and most useful clinical information and literature reviews on the management of AMD in a quick, easy to review format. The articles are written by a variety of authors in order to draw upon a wealth of expertise.

We hope that you will find the information timely and applicable to your practice, and that you will look forward to each issue.

Ingrid U. Scott, MD, MPH, Editor

We are pleased to have Ingrid U. Scott, MD, MPH as Editor of AMD Update.

Dr. Scott received both her medical degree and her master’s in public health degree from Johns Hopkins University. She completed ophthalmology residency training, fellowship training in vitreoretinal surgery and diseases and chief residency at the Bascom Palmer Eye Institute, University of Miami, where she stayed as Assistant Professor and then Associate Professor with tenure. Dr. Scott is currently Professor of Ophthalmology and Public Health Sciences at Penn State College of Medicine, where she also serves as the Ophthalmology Residency Program Director. Dr. Scott serves as Co-Chair of the Standard Care versus Corticosteroid for Retinal Vein Occlusion (SCORE) Study funded by the National Eye Institute, serves as the Chair of the Ophthalmic Technology Assessment Retina Panel of the American Academy of Ophthalmology, and has authored or co-authored over 200 peer-reviewed articles or book chapters.

Archived Newsletters

Issue 01 - Lucentis and Avastin: When to Use Which?
Issue 02 - The Role of Intravitreal Triamcinolone Acetonide in AMD Management
Issue 03 - Follow-up of AMD Patients Treated with Anti-VEGF Therapy: How to Monitor and Decide on Retreatment
Issue 04 - Is There a Place for Combination Therapy in Neovascular AMD?
Issue 05 - Should Lutein and Other Nutritional Supplements Be Given for the Therapy of Age-Related Macular Degeneration?
Issue 06 - Monitoring for the Conversion of Dry to Wet Age-Related Macular Degeneration
Issue 07 - Effect of Early Detection of Neovascular AMD on Visual Outcome
Issue 08 - The Role of Fluorescein Angiography in AMD Management
Issue 09 - How Long Should we Treat Patients with Anti-VEGF Therapy for Wet AMD Once the Lesion is Dry?
Issue 10 - Artificial Vision
Issue 11 - The Role of Photodynamic Therapy in AMD Management
Issue 12 - Value-Based Medicine and Interventions for Neovascular Age-Related Macular Degeneration
Issue 13 - Risk in AMD: Insight from Studies on Environmental Risk Factors, Genotype, and VEGF
Issue 14 - Intravitreal Anti-VEGF Plus PDT Combination Therapy for Neovascular AMD: A Clinical Perspective
Issue 15 - New OCT Devices: Implications for AMD Management
Issue 16 - Triple Therapy in Exudative AMD
Issue 17 - The Hidden Cost of Avastin AMD Therapy?
Issue 18 - The Complex Role of Innate Immunity in Ocular Angiogenesis
Issue 19 - Cell-based Therapies for AMD - a Cure on the Horizon?
Issue 20 - Cataract Surgery in the Patient with AMD
Issue 21 - A Combination of Anti-VEGF Therapy and Epi-retinal Radiation for the Treatment of Neovascular Age-related Macular Degeneration
Issue 22 - Neovascular AMD: Not Only VEGF
Issue 23 - Omega-3 Fatty Acid-Derived Resolvins and Protectins in Age-Related Macular Degeneration
Issue 24 - AMD Research: Current Needs and Future Directions
Issue 25 - Triple Therapy for the Treatment of CNV Due to AMD
Issue 26 - The Use of Autofluorescence Imaging in AMD
Issue 27 - Optical Coherence Tomography in Age-Related Macular Degeneration (AMD)
Issue 28 - Age-Related Macular Degeneration and Cardiovascular Disease
Issue 29 - Fluorescein Angiography in Age-Related Macular Degeneration
Issue 30 - Vision-Related Function in Patients with Age-Related Macular Degeneration
Issue 31 - VEGF-Trap Eye: What's the Evidence?
Issue 32 - The Role of Vitamin A in the Progression of Dry AMD
Issue 33 - Ciliary Neurotrophic Factor in the Treatment of Advanced Nonexudative Age-Related Macular Degeneration
Issue 34 - Genetics of Age-Related Macular Degeneration
Issue 35 - Managing the Patient with Bilateral Wet Macular Degeneration
Issue 36 - Management of Subretinal Hemorrhage
Issue 37 - Implantable Miniature Telescope for End-Stage Age-Related Macular Degeneration
Issue 38 - Spectral-Domain Optical Coherence Tomography: Comparing Commercially Available Systems for Managing Patients with Age-Related Macular DegenerationIssue 39 - Cataract Surgery for Patients with Advanced Age-Related Macular Degeneration
Issue 40 - Vitreoretinal Adhesion and Age-Related Macular Degeneration
Issue 41 - Comparison of Two Doses of Intravitreal Bevacizumab as Primary Treatment for Subfoveal CNV Associated with AMD at 24 Months: The Pan-American Collaborative Retina Study Group
Issue 42 - The "Treat and Extend" Dosing Regimen of Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration
Issue 43 - Combination Treatment with Epimacular Brachytherapy and Anti-VEGF Therapy for Age-Related Macular Degeneration
Issue 44 - The Role of Inflammation in the Pathogenesis of Age-Related Macular Degeneration
Issue 45 - Distinguishing Age-related Macular Degeneration from Other Macular Conditions
Issue 46 - Submacular Hemorrhage Associated with Age-Related Macular Degeneration: Favorable Response to Treatment With Intravitreal Ranibizumab Alone
Issue 47 - Novel Radiation Technique for the Treatment of Neovascular Age-Related Macular Degeneration
Issue 48 - Bullous Retinal Pigment Epithelial Detachment:Two Different Stories
Issue 49 - Genetics of AMD
Issue 50 - The Clinical Course of Adult "Vitelliform" Macular Lesions
Issue 51 - A Comparison of Local Anesthesia Techniques for Intravitreal Injections
Issue 52 - Monotherapy Treatment Strategies for Neovascular AMD Issue 53 - Platelet Derived Growth Factor (PDGF) Antagonism in Neovascular Age-Related Macular Degeneration




AWS-#2